Neuromuscular blockade by IgG antibodies from patients with Guillain- Barre syndrome: A macro-patch-clamp study

Annals of Neurology

Volumn 44, Issue 6, 1998, Pages 913-922

  Buchwald, Brigitte ^a,c   Toyka, Klaus V ^a   Zielasek, Jürgen ^a   Weishaupt, Andreas ^a   Schweiger, Susanna ^a   Dudel, Josef ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Neurologische Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; ELECTROPHYSIOLOGY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUSCLE WEAKNESS; NEUROTRANSMITTER RELEASE; PATCH CLAMP; PLASMAPHERESIS; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL;

EID: 0031794740     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440610     Document Type: Article

References (45)

1. Toyka KV, Heininger K. Humoral factors in peripheral nerve disease. Muscle Nerve 1987;10:222-232
2. Hartung H-P, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barré syndrome. Part I. Muscle Nerve 1995;18:137-153
3. Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-1104
4. Sumner AJ, Saida K, Saida T, et al. Acute conduction block associated with experimental anti-serum mediated demyelination of peripheral nerve. Ann Neurol 1982;11:469-477
5. Lisak RP, Kuchmy D, Armati-Gulson PJ, et al. Serum mediated Schwann cell cytotoxicity in the Guillain-Barré syndrome. Neurology 1984;34:1240-1243
6. Harrison BM, Hansen LA, Pollard JD, McLeod JG. Demyelination induced by serum from patients with Guillain-Barré syndrome. Ann Neurol 1984;15:163-170
7. Birchem R, Mithen FA, L'Empereur KM, Wessels MM. Ultrastructural effects of Guillain-Barré serum in cultures containing only rat Schwann cells and dorsal root ganglion neurons. Brain Res 1987;421:173-185
8. Saida K, Sumner AJ, Saida T, et al. Antiserum mediated demyelination: relationship between remyelination and functional recovery. Ann Neurol 1980;8:12-24
9. Oomes PG, van der Meché FGA, Markus Silvis L, et al. In vivo effects of sera from Guillain-Barré subgroups: an electrophysiological and histological study on rat nerves. Muscle Nerve 1991; 14:1013-1020
10. Santoro M, Uncini A, Corbo M, et al. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol 1992;31:385-390
11. Arasaki K, Kusunoki S, Kudo N, Kanazawa I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve 1993;16:587-593
12. Low PA, Schmelzer J, Dyck PJ, Kelly JJ. Endoneurial effects of sera from patients with acute inflammatory polyradiculoneuropathy: electrophysiologic studies on normal and demyelinated rat nerves. Neurology 1982;32:720-724
13. Silberberg DH, Manning MC, Schreiber AD. Tissue culture demyelination by normal human serum. Ann Neurol 1984;15: 575-580
14. Heininger K, Liebert UG, Toyka KV, et al. Reduction in nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin G. J Neurol Sci 1984;66:1-14
15. Seitz RJ, Heininger K, Schwendemann G, et al. The mouse blood-brain-barrier and blood-nerve-barrier for IgG: a tracer study by use of the avidin-biotin system. Acta Neuropathol (Berl) 1985;68:15-21
16. Brinkmeier H, Wollinsky KH, Hülser PJ, et al. The acute paralysis in Guillain-Barre syndrome is related to a Na+ channel blocking factor in the cerebrospinal fluid. Pflugers Arch 1992; 421:552-557
17. Würz A, Brinkmeier H, Wollinsky KH, et al. Cerebrospinal fluid and serum from patients with inflammatory polyradiculoneuropathy have opposite effects on sodium channels. Muscle Nerve 1995;18:772-781
18. Brinkmeier H, Seewald MJ, Wollinsky KH, Rüdel R. On the nature of endogenous antiexcitatory factors in the cerebrospinal fluid of patients with demyelinating neurological disease. Muscle Nerve 1996;19:54-62
19. Gregson NA, Koblar S, Hughes RA. Antibodies to gangliosides in Guillain-Barre syndrome: specificity and relationship to clinical features. Q J Med 1993;86:111-117
20. Enders U, Karch H, Toyka KV, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 1993;34:136-144
21. Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol 1993;34:130-135
22. Johnson D, Sato S, Quarles RH, et al. Quantitation of the myelin associated glycoprotein in human nervous tissue from controls and multiple sclerosis patients. J Neurochem 1986;46: 1086-1093
23. Thomas FP, Trojaborg W, Nagy C, et al. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol (Berl) 1991;82:378-383
24. Roberts M, Willison H, Vincent A, Newsom-Davis J. Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann Neurol 1995;38:111-118
25. Buchwald B, Weishaupt A, Toyka KV, Dudel J. Immunoglobulin G from patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice. Neurosci Lett 1995;201:163-166
26. Buchwald B, Weishaupt A, Toyka KV, Dudel J. Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals. Eur J Neurosci 1998;10:281-290
27. Luijckx GJ, Vies J, De Baets M, et al. Guillain-Barré syndrome in mother and newborn child. Lancet 1997;349:27 (Letter)
28. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27(Suppl):21-24
29. Ropper AH. The Guillain-Barré syndrome. N Engl J Med 1992;326:1130-1136
30. Zielasek J, Ritter G, Magi S, et al. A comparative trial of antiglycoconjugate antibody assays: IgM antibodies to GM1. J Neurol 1994;241:475-480
31. Dudel J. Calcium dependence of quantal release triggered by graded depolarization pulses to nerve terminals on crayfish and frog muscle. Pflugers Arch 1989;415:289-298
32. Hafer Macko C, Hsieh ST, Li CY, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 1996;40:635-644
33. Hartung HP, Toyka KV, Griffin JW. Guillain-Barré syndrome and chronic demyelinating inflammatory polyradiculoneuropathy. In: Antel J, Birnbaum G, Hartung HP, eds. Clinical neuroimmunology. Oxford, UK: Blackwell Scientific, 1998:294-306
34. Barrett-Jolley R, Byrne N, Vincent A, Newsom-Davis J. Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line. Pflugers Arch 1994;428:492-498
35. Takigawa T, Yasuda H, Kikkawa R, et al. Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers. Ann Neurol 1995;37:436-442
36. Hirota N, Kaji R, Bostock H, et al. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain 1997;120:2159-2169
37. 2+ inflow to quantal, phasic transmitter release from nerve terminals of frog muscle. Pflugers Arch 1992;422:129-142
38. Bufler J, Franke C, Parnas H, Dudel J. Open channel block by physostigmine and procaine in embryonic-like nicotinic receptors of mouse muscle. Eur J Neurosci 1996;8:677-687
39. Ropper AH, Wijdicks EFM, Bradley TT. Guillain-Barré syndrome. Philadelphia: FA Davis, 1991:229-232
40. Feasby TE, Hahn AF, Brown WF, et al. Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? J Neurol Sci 1993;1165:185-192
41. Illa I, Ortiz N, Gallard E, et al. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann Neurol 1995;38:218-224
42. Ho TW, Hsieh S-T, Nachamkin I, et al. Motor nerve terminal degenerarion provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology 1997;48:717-724
43. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-1126
44. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993;178:1771-1775
45. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349:225-230